Swiss pharmaceutical giant Roche gets US green light to sell a drug that treats a diabetes-related illness linked to blindness. The US Food and Drug Administration's (FDA) decision means that Roche can take Lucentis to the US to treat diabetic macular oedema (DME), a condition that causes swelling, blurred vision and blindness in people with diabetes. In a statement Roche called the development the "first major treatment advance in more than 25 years ...Tuesday, 14 August 2012
Roche to Sell Diabetes Eye Drug
Swiss pharmaceutical giant Roche gets US green light to sell a drug that treats a diabetes-related illness linked to blindness. The US Food and Drug Administration's (FDA) decision means that Roche can take Lucentis to the US to treat diabetic macular oedema (DME), a condition that causes swelling, blurred vision and blindness in people with diabetes. In a statement Roche called the development the "first major treatment advance in more than 25 years ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment